Saudi Arabia SFDA registration ME0000000051SFDAA00757
MAGLUMI Tacrolimus (CLIA)
Saudi Arabia·IVD·Shenzhen New Industries Biomedical Engineering Co., Ltd ( SNIBE )·3ActiveProduct information
Quantitative determination of Tacrolimus in human whole blood
Device classification
- Risk Class
- 3
- Product Category
- IVD
- Product Type
- 2
Registration information
- Registration ID
- ME0000000051SFDAA00757
- Authorization ID
- MDMA-2-2025-0006
- Status
- Active
- Expire Date
- January 01, 2028
Manufacturer
- Manufacturer Name
- Shenzhen New Industries Biomedical Engineering Co., Ltd ( SNIBE )
Model information
- Model ID(s)
- 1302573003M,1306573003M,1307573003M
Product accessories
[]
About this record
Access comprehensive regulatory information for MAGLUMI Tacrolimus (CLIA) in the Saudi Arabia medical device market through Pure Global AI's free database. This 3 device is registered with Saudi Arabia SFDA under registration number ME0000000051SFDAA00757 and manufactured by Shenzhen New Industries Biomedical Engineering Co., Ltd ( SNIBE ).
This page provides complete registration details including product category (IVD), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official Data3